Diabetes Therapy Quiz
Quiz Summary
0 of 78 Questions completed
Questions:
Information
You have already completed this quiz. You cannot start it again.
Quiz is loading…
You must sign in or sign up to take this quiz.
You must first complete the following:
Results
Quiz complete. Results are being recorded.
Results
0 of 78 Questions answered correctly
Your Time:
Time has elapsed.
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Board Review Endocrinology 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- Current
- Review
- Answered
- Correct
- Incorrect
- 1. Question
A 54-year-old woman with a history of Type 2 Diabetes Mellitus (T2DM) presents with a recent weight gain. She is currently on Metformin and a 2nd Generation SU. Which of the following changes in her medication regimen might assist with her weight gain issue?
CorrectIncorrect - 2. Question
A 54-year-old woman with a history of Type 2 Diabetes Mellitus (T2DM) presents with a recent weight gain. She is currently on Metformin and a 2nd Generation SU. Which of the following changes in her medication regimen might assist with her weight gain issue?
CorrectIncorrect - 3. Question
A 60-year-old man with a history of T2DM, congestive heart failure (CHF), and renal disease is currently taking DPP-4 inhibitors for his diabetes management. Which other medication, when added, might have beneficial effects on both his CHF and renal disease?
CorrectIncorrect - 4. Question
A 60-year-old man with a history of T2DM, congestive heart failure (CHF), and renal disease is currently taking DPP-4 inhibitors for his diabetes management. Which other medication, when added, might have beneficial effects on both his CHF and renal disease?
CorrectIncorrect - 5. Question
A 65-year-old woman with a history of T2DM presents with frequent hypoglycemic episodes. She is currently on 2nd Generation SU. Which of the following medication switches is likely to reduce her risk of hypoglycemia?
CorrectIncorrect - 6. Question
A 65-year-old woman with a history of T2DM presents with frequent hypoglycemic episodes. She is currently on 2nd Generation SU. Which of the following medication switches is likely to reduce her risk of hypoglycemia?
CorrectIncorrect - 7. Question
A 45-year-old woman with T2DM has a current HbA1c level of 9.2%. Her diabetes is currently managed with diet and exercise. What can you expect from the addition of a glucose-lowering drug in this patient?
CorrectIncorrect - 8. Question
A 45-year-old woman with T2DM has a current HbA1c level of 9.2%. Her diabetes is currently managed with diet and exercise. What can you expect from the addition of a glucose-lowering drug in this patient?
CorrectIncorrect - 9. Question
A 60-year-old man with T2DM and significant insulin resistance has a limited response to his current medication, a sulfonylurea. What medication change would likely increase his response?
CorrectIncorrect - 10. Question
A 60-year-old man with T2DM and significant insulin resistance has a limited response to his current medication, a sulfonylurea. What medication change would likely increase his response?
CorrectIncorrect - 11. Question
A 67-year-old woman with T2DM presents with recurring episodes of hypoglycemia. She is currently on a sulfonylurea with active metabolites. Considering her hypoglycemia episodes, which sulfonylurea might be a better option for her?
CorrectIncorrect - 12. Question
A 67-year-old woman with T2DM presents with recurring episodes of hypoglycemia. She is currently on a sulfonylurea with active metabolites. Considering her hypoglycemia episodes, which sulfonylurea might be a better option for her?
CorrectIncorrect - 13. Question
A 79-year-old man with T2DM, chronic kidney disease (stage 3), and a recent history of mild hypoglycemic episodes is currently on Glyburide. What adjustment should be considered in his treatment?
CorrectIncorrect - 14. Question
A 79-year-old man with T2DM, chronic kidney disease (stage 3), and a recent history of mild hypoglycemic episodes is currently on Glyburide. What adjustment should be considered in his treatment?
CorrectIncorrect - 15. Question
A 56-year-old man with newly diagnosed T2DM is prescribed Glimepiride. He does not have any other comorbidities. What should be the recommended starting dose and the progression of his treatment plan?
CorrectIncorrect - 16. Question
A 56-year-old man with newly diagnosed T2DM is prescribed Glimepiride. He does not have any other comorbidities. What should be the recommended starting dose and the progression of his treatment plan?
CorrectIncorrect - 17. Question
A 58-year-old male with a history of T2DM is brought into the clinic due to repeated episodes of hypoglycemia. His current medications include glyburide. His liver function tests are slightly elevated. Which of the following factors might be contributing to his hypoglycemic episodes?
CorrectIncorrectConsider the role of the liver in metabolizing sulfonylureas and the common side effects of sulfonylureas.
- 18. Question
A 58-year-old male with a history of T2DM is brought into the clinic due to repeated episodes of hypoglycemia. His current medications include glyburide. His liver function tests are slightly elevated. Which of the following factors might be contributing to his hypoglycemic episodes?
CorrectIncorrectConsider the role of the liver in metabolizing sulfonylureas and the common side effects of sulfonylureas.
- 19. Question
You are treating a 72-year-old patient with T2DM who has recently been experiencing a high frequency of severe hypoglycemic episodes. He is currently on glyburide. Considering his age and hypoglycemia risk, what would be the most appropriate action?
CorrectIncorrectConsider the duration of action of different sulfonylureas and the patient's risk for hypoglycemia.
- 20. Question
You are treating a 72-year-old patient with T2DM who has recently been experiencing a high frequency of severe hypoglycemic episodes. He is currently on glyburide. Considering his age and hypoglycemia risk, what would be the most appropriate action?
CorrectIncorrectConsider the duration of action of different sulfonylureas and the patient's risk for hypoglycemia.
- 21. Question
A 65-year-old male patient with T2DM has been experiencing secondary failure of sulfonylurea therapy. What is the likely reason for this failure?
CorrectIncorrectConsider the effects of sulfonylurea therapy over time and the role of beta cells in insulin production.
- 22. Question
A 65-year-old male patient with T2DM has been experiencing secondary failure of sulfonylurea therapy. What is the likely reason for this failure?
CorrectIncorrectConsider the effects of sulfonylurea therapy over time and the role of beta cells in insulin production.
- 23. Question
A 72-year-old woman with type 2 diabetes has been managed with metformin but her A1c remains suboptimal. She has no known renal or liver disease. You consider adding a sulfonylurea to her regimen. Which of the following sulfonylureas would you prefer to avoid considering her age?
CorrectIncorrectConsider the age of the patient and risk of hypoglycemia.
- 24. Question
A 72-year-old woman with type 2 diabetes has been managed with metformin but her A1c remains suboptimal. She has no known renal or liver disease. You consider adding a sulfonylurea to her regimen. Which of the following sulfonylureas would you prefer to avoid considering her age?
CorrectIncorrectConsider the age of the patient and risk of hypoglycemia.
- 25. Question
A 65-year-old male with type 2 diabetes and a known deficiency in glucose 6-phosphate dehydrogenase (G6PD) is being considered for sulfonylurea therapy. What possible side effect should you particularly be cautious about?
CorrectIncorrectConsider the genetic deficiency of the patient.
- 26. Question
A 65-year-old male with type 2 diabetes and a known deficiency in glucose 6-phosphate dehydrogenase (G6PD) is being considered for sulfonylurea therapy. What possible side effect should you particularly be cautious about?
CorrectIncorrectConsider the genetic deficiency of the patient.
- 27. Question
A 52-year-old woman with type 2 diabetes and obesity is being evaluated for her suboptimal glycemic control. She is currently on metformin and lifestyle modifications. You consider adding another antidiabetic agent to her regimen. What would be a potential disadvantage if you choose a sulfonylurea for her?
CorrectIncorrectConsider the current condition of the patient and the potential side effects of sulfonylureas.
- 28. Question
A 52-year-old woman with type 2 diabetes and obesity is being evaluated for her suboptimal glycemic control. She is currently on metformin and lifestyle modifications. You consider adding another antidiabetic agent to her regimen. What would be a potential disadvantage if you choose a sulfonylurea for her?
CorrectIncorrectConsider the current condition of the patient and the potential side effects of sulfonylureas.
- 29. Question
A 65-year-old patient with a history of type 2 diabetes, hypertension, and fatty liver disease is currently on metformin therapy. His HbA1c level is 7.8%. His primary issue is postprandial hyperglycemia, while his fasting glucose levels are near normal. Which antidiabetic medication would be the most suitable for this patient?
CorrectIncorrectConsider the patient's main issue which is postprandial hyperglycemia.
- 30. Question
A 65-year-old patient with a history of type 2 diabetes, hypertension, and fatty liver disease is currently on metformin therapy. His HbA1c level is 7.8%. His primary issue is postprandial hyperglycemia, while his fasting glucose levels are near normal. Which antidiabetic medication would be the most suitable for this patient?
CorrectIncorrectConsider the patient's main issue which is postprandial hyperglycemia.
- 31. Question
A 48-year-old male, newly diagnosed with type 2 diabetes, has an HbA1c of 9.2%. The patient eats meals at irregular times and has both high fasting and postprandial glucose levels. Which drug would be most suitable for him?
CorrectIncorrectConsider the fact that the patient has both high fasting and postprandial glucose levels and eats meals at irregular times.
- 32. Question
A 48-year-old male, newly diagnosed with type 2 diabetes, has an HbA1c of 9.2%. The patient eats meals at irregular times and has both high fasting and postprandial glucose levels. Which drug would be most suitable for him?
CorrectIncorrectConsider the fact that the patient has both high fasting and postprandial glucose levels and eats meals at irregular times.
- 33. Question
A 60-year-old patient with type 2 diabetes and liver impairment is taking ketoconazole for a fungal infection. He is also on meglitinide therapy. What risk is associated with the combination of meglitinides and ketoconazole?
CorrectIncorrectConsider the metabolic pathway of meglitinides and the effect of ketoconazole on this pathway
- 34. Question
A 60-year-old patient with type 2 diabetes and liver impairment is taking ketoconazole for a fungal infection. He is also on meglitinide therapy. What risk is associated with the combination of meglitinides and ketoconazole?
CorrectIncorrectConsider the metabolic pathway of meglitinides and the effect of ketoconazole on this pathway
- 35. Question
A 52-year-old man with a history of type 2 diabetes mellitus comes to the clinic. He is currently on metformin but his fasting glucose levels are not well controlled. He reports taking his metformin twice daily with breakfast and dinner. The doctor decides to increase his dose. Which of the following would be the maximum daily dose of metformin that this patient can be prescribed?
CorrectIncorrectMetformin has a specific maximum dosage limit.
- 36. Question
A 52-year-old man with a history of type 2 diabetes mellitus comes to the clinic. He is currently on metformin but his fasting glucose levels are not well controlled. He reports taking his metformin twice daily with breakfast and dinner. The doctor decides to increase his dose. Which of the following would be the maximum daily dose of metformin that this patient can be prescribed?
CorrectIncorrectMetformin has a specific maximum dosage limit.
- 37. Question
A 65-year-old woman with type 2 diabetes mellitus is currently on metformin therapy. She is concerned about gaining weight from her medications. Which of the following is the most likely effect of metformin on her body weight?
CorrectIncorrectConsider the common side effects of metformin.
- 38. Question
A 65-year-old woman with type 2 diabetes mellitus is currently on metformin therapy. She is concerned about gaining weight from her medications. Which of the following is the most likely effect of metformin on her body weight?
CorrectIncorrectConsider the common side effects of metformin.
- 39. Question
A 45-year-old man with type 2 diabetes mellitus is concerned about the potential side effects of his medications. He is currently prescribed metformin. What is the most common side effect of metformin?
CorrectIncorrectGastrointestinal side effects are common with metformin use.
- 40. Question
A 45-year-old man with type 2 diabetes mellitus is concerned about the potential side effects of his medications. He is currently prescribed metformin. What is the most common side effect of metformin?
CorrectIncorrectGastrointestinal side effects are common with metformin use.
- 41. Question
A 65-year-old woman with a history of Type 2 diabetes managed with metformin comes to the clinic for routine follow-up. She also has a history of chronic kidney disease (eGFR 35mL/min/1.73 m2). She reports experiencing recent worsening of fatigue. What should be the most appropriate next step in her management?
CorrectIncorrectRemember metformin dose adjustments in relation to kidney function.
- 42. Question
A 65-year-old woman with a history of Type 2 diabetes managed with metformin comes to the clinic for routine follow-up. She also has a history of chronic kidney disease (eGFR 35mL/min/1.73 m2). She reports experiencing recent worsening of fatigue. What should be the most appropriate next step in her management?
CorrectIncorrectRemember metformin dose adjustments in relation to kidney function.
- 43. Question
A 40-year-old woman with polycystic ovary syndrome (PCOS) and type 2 diabetes has been treated with metformin. She has been feeling fatigued and reports experiencing paresthesias in her hands and feet. Laboratory tests reveal a decrease in B12 levels. What should be the most appropriate next step in her management?
CorrectIncorrectRemember the side effects of metformin.
- 44. Question
A 40-year-old woman with polycystic ovary syndrome (PCOS) and type 2 diabetes has been treated with metformin. She has been feeling fatigued and reports experiencing paresthesias in her hands and feet. Laboratory tests reveal a decrease in B12 levels. What should be the most appropriate next step in her management?
CorrectIncorrectRemember the side effects of metformin.
- 45. Question
A 50-year-old man with a history of diabetes, chronic alcoholism, and congestive heart failure is scheduled to undergo an iodinated contrast procedure. His eGFR is 40 mL/min/1.73 m2. He is currently on metformin. What is the most appropriate management of his metformin before the procedure?
CorrectIncorrectRemember the guidelines for metformin use around iodinated contrast procedures.
- 46. Question
A 50-year-old man with a history of diabetes, chronic alcoholism, and congestive heart failure is scheduled to undergo an iodinated contrast procedure. His eGFR is 40 mL/min/1.73 m2. He is currently on metformin. What is the most appropriate management of his metformin before the procedure?
CorrectIncorrectRemember the guidelines for metformin use around iodinated contrast procedures.
- 47. Question
A 55-year-old patient with impaired glucose tolerance and a liver biopsy confirmed diagnosis of NASH is under your treatment. He has recently been randomized to pioglitazone 45 mg/day. What would you expect to observe after six months of therapy?
CorrectIncorrect - 48. Question
A 55-year-old patient with impaired glucose tolerance and a liver biopsy confirmed diagnosis of NASH is under your treatment. He has recently been randomized to pioglitazone 45 mg/day. What would you expect to observe after six months of therapy?
CorrectIncorrect - 49. Question
A 60-year-old man with T2DM is being treated with a combination of TZDs and insulin. He presents with newly developed edema. What could be the possible reason?
CorrectIncorrect - 50. Question
A 60-year-old man with T2DM is being treated with a combination of TZDs and insulin. He presents with newly developed edema. What could be the possible reason?
CorrectIncorrect - 51. Question
Which of the following is true regarding the effects of TZDs (Thiazolidinediones) on Congestive Heart Failure (CHF) based on the data from various studies?
CorrectIncorrectTZDs are known to cause fluid retention.
- 52. Question
Which of the following is true regarding the effects of TZDs (Thiazolidinediones) on Congestive Heart Failure (CHF) based on the data from various studies?
CorrectIncorrectTZDs are known to cause fluid retention.
- 53. Question
What effect do TZDs have on bone health, particularly in women?
CorrectIncorrectConsider the dual impact of TZDs on bone health – both on bone mineral density and fracture risk.
- 54. Question
What is the association between pioglitazone use and bladder cancer based on the given data?
CorrectIncorrectConsider the findings from the PROactive study.
- 55. Question
A 56-year-old patient with a history of type 2 diabetes mellitus, cardiovascular disease, and nonalcoholic steatohepatitis (NASH) has been prescribed pioglitazone. Which of the following is an advantage of pioglitazone for this patient?
CorrectIncorrectPioglitazone, a type of Thiazolidinedione (TZD), has certain advantages and disadvantages. Choose the option that represents an advantage.
- 56. Question
A 45-year-old patient with type 2 diabetes mellitus is being treated with an alpha-glucosidase inhibitor and insulin. In case of hypoglycemia, what should be the immediate treatment?
CorrectIncorrectConsider the mechanism of action of alpha-glucosidase inhibitors in the context of hypoglycemia management.
- 57. Question
What is the effect of alpha-glucosidase inhibitors on cardiovascular disease in patients with diabetes?
CorrectIncorrectLook at the results of different trials concerning the effects of alpha-glucosidase inhibitors on cardiovascular disease.
- 58. Question
Which of the following is an advantage of alpha-glucosidase inhibitors like Acarbose?
CorrectIncorrectLook for the advantages of alpha-glucosidase inhibitors.
- 59. Question
Which of the following statements is true regarding the effects of SGLT2 inhibitors on glycemic control?
CorrectIncorrectRemember that SGLT2 inhibitors work by promoting the excretion of glucose in the urine.Q2:) Which of the following best describes the effect of SGLT2 inhibitors on weight and lipid levels?
- 60. Question
Which of the following statements is true about the cardiovascular effects of SGLT2 inhibitors, according to the EMPA-REG Outcome Trial and the CANVAS Trial?
CorrectIncorrectRemember the findings from the EMPA-REG Outcome Trial and the CANVAS Trial.
- 61. Question
What is one of the most common side effects of alpha-glucosidase inhibitors like Acarbose?
CorrectIncorrectReview the common side effects of alpha-glucosidase inhibitors.
- 62. Question
What is the mechanism of action of SGLT2 inhibitors in the management of diabetes?
CorrectIncorrectConsider how SGLT2 inhibitors affect glucose levels in the body.
- 63. Question
A 68-year-old patient with Type 2 Diabetes Mellitus (T2DM), chronic kidney disease, and a history of heart failure is in the clinic for a medication review. Based on the CREDENCE and DECLARE-TIMI 58 Trials, which drug would you consider adding to their regimen?
CorrectIncorrectRemember the outcomes of the CREDENCE and DECLARE-TIMI 58 Trials.
- 64. Question
Which of the following drugs was shown in the DAPA HF trial to be beneficial in patients with pre-existing heart failure, regardless of whether they had diabetes?
CorrectIncorrectThink about the results of the DAPA HF trial.
- 65. Question
Based on the results of the EMPEROR-Reduced and EMPEROR-Preserved Trials, which drug would you consider adding to the regimen of a patient with class II heart failure and an ejection fraction of 40% or less, regardless of their diabetes status?
CorrectIncorrectReflect on the results of the EMPEROR-Reduced and EMPEROR-Preserved Trials.
- 66. Question
What effect do TZDs have on bone health, particularly in women?
CorrectIncorrectConsider the dual impact of TZDs on bone health – both on bone mineral density and fracture risk.
- 67. Question
What is the association between pioglitazone use and bladder cancer based on the given data?
CorrectIncorrectConsider the findings from the PROactive study.
- 68. Question
A 56-year-old patient with a history of type 2 diabetes mellitus, cardiovascular disease, and nonalcoholic steatohepatitis (NASH) has been prescribed pioglitazone. Which of the following is an advantage of pioglitazone for this patient?
CorrectIncorrectPioglitazone, a type of Thiazolidinedione (TZD), has certain advantages and disadvantages. Choose the option that represents an advantage.
- 69. Question
A 45-year-old patient with type 2 diabetes mellitus is being treated with an alpha-glucosidase inhibitor and insulin. In case of hypoglycemia, what should be the immediate treatment?
CorrectIncorrectConsider the mechanism of action of alpha-glucosidase inhibitors in the context of hypoglycemia management.
- 70. Question
What is the effect of alpha-glucosidase inhibitors on cardiovascular disease in patients with diabetes?
CorrectIncorrectLook at the results of different trials concerning the effects of alpha-glucosidase inhibitors on cardiovascular disease.
- 71. Question
Which of the following is an advantage of alpha-glucosidase inhibitors like Acarbose?
CorrectIncorrectLook for the advantages of alpha-glucosidase inhibitors.
- 72. Question
Which of the following statements is true regarding the effects of SGLT2 inhibitors on glycemic control?
CorrectIncorrectRemember that SGLT2 inhibitors work by promoting the excretion of glucose in the urine.Q2:) Which of the following best describes the effect of SGLT2 inhibitors on weight and lipid levels?
- 73. Question
Which of the following statements is true about the cardiovascular effects of SGLT2 inhibitors, according to the EMPA-REG Outcome Trial and the CANVAS Trial?
CorrectIncorrectRemember the findings from the EMPA-REG Outcome Trial and the CANVAS Trial.
- 74. Question
What is one of the most common side effects of alpha-glucosidase inhibitors like Acarbose?
CorrectIncorrectReview the common side effects of alpha-glucosidase inhibitors.
- 75. Question
What is the mechanism of action of SGLT2 inhibitors in the management of diabetes?
CorrectIncorrectConsider how SGLT2 inhibitors affect glucose levels in the body.
- 76. Question
A 68-year-old patient with Type 2 Diabetes Mellitus (T2DM), chronic kidney disease, and a history of heart failure is in the clinic for a medication review. Based on the CREDENCE and DECLARE-TIMI 58 Trials, which drug would you consider adding to their regimen?
CorrectIncorrectRemember the outcomes of the CREDENCE and DECLARE-TIMI 58 Trials.
- 77. Question
Which of the following drugs was shown in the DAPA HF trial to be beneficial in patients with pre-existing heart failure, regardless of whether they had diabetes?
CorrectIncorrectThink about the results of the DAPA HF trial.
- 78. Question
Based on the results of the EMPEROR-Reduced and EMPEROR-Preserved Trials, which drug would you consider adding to the regimen of a patient with class II heart failure and an ejection fraction of 40% or less, regardless of their diabetes status?
CorrectIncorrectReflect on the results of the EMPEROR-Reduced and EMPEROR-Preserved Trials.
Same here as well. Nateglinide is the correct answer but shows up as incorrect.
Looks like hemolytic anemia is the correct answer (as mentioned in the hint as well), but it comes up as incorrect. Please do correct. Thanks
I am answering the correct answers but give me I am answering incorrect😢